BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33942253)

  • 21. Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.
    El Zein D; Hughes M; Kumar S; Peng X; Oyasiji T; Jabbour H; Khoury T
    Clin Breast Cancer; 2017 Aug; 17(5):382-391. PubMed ID: 28529029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Features of Metaplastic Breast Carcinoma: An Infrequent Subtype of Triple Negative Breast Carcinoma.
    González-Martínez S; Pérez-Mies B; Carretero-Barrio I; Palacios-Berraquero ML; Perez-García J; Cortés J; Palacios J
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32650408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
    Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A
    Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Profiling of the Metaplastic Spindle Cell Carcinoma of the Breast Reveals Potentially Targetable Biomarkers.
    Vranic S; Stafford P; Palazzo J; Skenderi F; Swensen J; Xiu J; Spetzler D; Gatalica Z
    Clin Breast Cancer; 2020 Aug; 20(4):326-331.e1. PubMed ID: 32197944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The molecular genetic make-up of male breast cancer.
    Moelans CB; de Ligt J; van der Groep P; Prins P; Besselink NJM; Hoogstraat M; Ter Hoeve ND; Lacle MM; Kornegoor R; van der Pol CC; de Leng WWJ; Barbé E; van der Vegt B; Martens J; Bult P; Smit VTHBM; Koudijs MJ; Nijman IJ; Voest EE; Selenica P; Weigelt B; Reis-Filho JS; van der Wall E; Cuppen E; van Diest PJ
    Endocr Relat Cancer; 2019 Oct; 26(10):779-794. PubMed ID: 31340200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metaplastic Breast Cancer: Molecular Typing and Identification of Potential Targeted Therapies at a Single Institution.
    Edenfield J; Schammel C; Collins J; Schammel D; Edenfield WJ
    Clin Breast Cancer; 2017 Feb; 17(1):e1-e10. PubMed ID: 27568101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance.
    Hu ZY; Xie N; Tian C; Yang X; Liu L; Li J; Xiao H; Wu H; Lu J; Gao J; Hu X; Cao M; Shui Z; Xiao M; Tang Y; He Q; Chang L; Xia X; Yi X; Liao Q; Ouyang Q
    EBioMedicine; 2018 Jun; 32():111-118. PubMed ID: 29807833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic features and outcomes of metaplastic breast carcinoma: comparison with invasive ductal carcinoma of the breast.
    Park HS; Park S; Kim JH; Lee JH; Choi SY; Park BW; Lee KS
    Yonsei Med J; 2010 Nov; 51(6):864-9. PubMed ID: 20879052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer.
    Mosele F; Stefanovska B; Lusque A; Tran Dien A; Garberis I; Droin N; Le Tourneau C; Sablin MP; Lacroix L; Enrico D; Miran I; Jovelet C; Bièche I; Soria JC; Bertucci F; Bonnefoi H; Campone M; Dalenc F; Bachelot T; Jacquet A; Jimenez M; André F
    Ann Oncol; 2020 Mar; 31(3):377-386. PubMed ID: 32067679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations.
    Holstege H; Horlings HM; Velds A; Langerød A; Børresen-Dale AL; van de Vijver MJ; Nederlof PM; Jonkers J
    BMC Cancer; 2010 Nov; 10():654. PubMed ID: 21118481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metaplastic Breast Carcinoma: Analysis of Clinical and Pathologic Characteristics - A Case Series.
    Salimoğlu S; Sert İ; Emiroğlu M; Karaali C; Kuzukıran D; Kırmızı YA; Diniz G; Aydın C
    J Breast Health; 2016 Apr; 12(2):63-66. PubMed ID: 28331735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
    Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A giant metaplastic breast carcinoma with osseous differentiation: A rare case report and review of the literature.
    Do TA; Nguyen AQ; Van Nguyen T; Vu PT; Tran HT
    Int J Surg Case Rep; 2024 Jul; 120():109840. PubMed ID: 38852558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metaplastic breast cancer: clinicopathological features and its prognosis.
    Lee H; Jung SY; Ro JY; Kwon Y; Sohn JH; Park IH; Lee KS; Lee S; Kim SW; Kang HS; Ko KL; Ro J
    J Clin Pathol; 2012 May; 65(5):441-6. PubMed ID: 22412048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.
    Ng CKY; Bidard FC; Piscuoglio S; Geyer FC; Lim RS; de Bruijn I; Shen R; Pareja F; Berman SH; Wang L; Pierga JY; Vincent-Salomon A; Viale A; Norton L; Sigal B; Weigelt B; Cottu P; Reis-Filho JS
    Clin Cancer Res; 2017 Aug; 23(15):4402-4415. PubMed ID: 28351929
    [No Abstract]   [Full Text] [Related]  

  • 36. Metaplastic carcinoma of the breast with mesenchymal differentiation (carcinosarcoma). A unique presentation of an aggressive malignancy and literature review.
    Salemis NS
    Breast Dis; 2018; 37(3):169-175. PubMed ID: 29504519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metaplastic breast carcinoma: Analysis of 31 cases from a single institute.
    Fayaz S; Demian GA; Eissa HE; Amanguno H; Abuzalouf S
    J Egypt Natl Canc Inst; 2017 Sep; 29(3):141-145. PubMed ID: 28669452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unique characteristics and failure patterns of metaplastic breast cancer in contrast to invasive ductal carcinoma: a retrospective multicenter case-control study (KROG 13-07).
    Yu JI; Choi DH; Huh SJ; Ahn SJ; Lee JS; Shin KH; Kwon Y; Kim YB; Suh CO; Kim JH; Cho J; Kim IA; Lee JH; Park W
    Clin Breast Cancer; 2015 Apr; 15(2):e105-15. PubMed ID: 25459069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibromatosis-like metaplastic carcinoma: a case report and review of the literature.
    Victoor J; Bourgain C; Vander Borght S; Vanden Bempt I; De Rop C; Floris G
    Diagn Pathol; 2020 Mar; 15(1):20. PubMed ID: 32127014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metaplastic carcinoma of the breast with osteocartilaginous heterologous elements.
    Chhieng C; Cranor M; Lesser ME; Rosen PP
    Am J Surg Pathol; 1998 Feb; 22(2):188-94. PubMed ID: 9500219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.